Based on formulation experience and stability studies on polyphenolic compounds, a pH range of approximately 4.0–5.5 is generally considered favorable for maintaining glabridin stability in cosmetic systems. This is a stability-based requirement: glabridin's polyphenolic structure contains multiple phenolic hydroxyl groups that remain in a protonated state under mildly acidic conditions, keeping the molecule most stable. As the environment approaches neutral or alkaline pH above 6.5, the phenolic hydroxyl groups begin to deprotonate, increasing susceptibility to oxidative discoloration and degradation.

The Chemistry Behind the pH Requirement

Glabridin is a polyphenolic isoflavane compound containing two phenolic hydroxyl groups at the 2′- and 4′-positions of the ring structure. These groups are critical to its tyrosinase-inhibiting activity — and they are the primary site of pH-driven oxidative degradation.

Above pH 7.0, glabridin's phenolic hydroxyl groups deprotonate more readily to form phenoxide anions, significantly increasing oxidative sensitivity and accelerating radical-mediated oxidative degradation. This process generates conjugated oxidation products, manifesting as progressive color deepening accompanied by active content loss.

The degradation shows significant pH-dependent acceleration: above pH 7.0, system stability decreases markedly and the formulation may show higher sensitivity to further pH changes. Under accelerated stability conditions (ICH Q1A(R2), 40°C / 75% RH), formulations at pH 7.5 generally show lower stability than those at pH 5.5.

The pH stability behavior documented in published stability data (Ao et al., Natural Product Communications, 2010, DOI: 10.1177/1934578X1000501214) shows glabridin is stable under acidic and neutral conditions, with significant decomposition in alkaline conditions — consistent with this mechanistic understanding.

pH Stability Windows

pH RangeStabilityPractical Implication
4.0–5.5FavorableTarget range for most leave-on applications
5.5–6.5GoodAcceptable; reinforce antioxidant and chelation system
6.5–7.0MarginalElevated risk; run accelerated stability before commercializing
>7.0PoorAccelerated oxidative degradation under alkaline conditions, progressive color change — avoid
Curve chart showing glabridin concentration across pH 1–13, stable plateau at pH 1–6 with sharp decline above pH 7
Fig. 1 — Effect of pH on glabridin stability. Concentration remains stable across pH 1–6, then declines sharply above pH 7. At pH 13, concentration drops to approximately 7 µg/mL. Data: Ao et al., Natural Product Communications, 2010.

For most leave-on brightening formats (serums, emulsions, toners, essences), pH 4.5–5.5 is both technically favorable for glabridin and cosmetically appropriate — sitting within the physiological range of healthy skin surface pH (4.5–5.5), supporting barrier function and microbiome balance alongside active stability.

Buffer System Selection

Formulation pH may drift during storage, particularly in emulsions, where chemical reactions within the aqueous phase and at the oil–water interface can alter the system over time. In addition, acidic or alkaline degradation of co-ingredients may further shift the overall equilibrium. A properly buffered aqueous phase is required.

Recommended buffer systems

Buffer SystemEffective pH RangeNotes
Citric acid / Sodium citrate3.0–6.2Versatile; cosmetically well-tolerated; mild chelating effect on metal ions
Lactic acid / Sodium lactate3.6–5.8Skin-identical; supports barrier function; NMF component
Gluconolactone / Sodium gluconate3.5–6.0PHA; mild exfoliant; adds multifunctional benefit

Systems to avoid with glabridin

Buffer / SystemConcern
Phosphate buffersWeak metal chelation; lower oxidation protection compared to organic buffer systems
Sodium bicarbonate / carbonateAlkaline range; incompatible with glabridin stability
Triethanolamine (TEA) adjustmentNot a buffer; weak pH stability control

Citric acid/sodium citrate is the most commonly used and most practical choice. Its mild chelating effect on metal ions provides a secondary benefit alongside pH buffering — reducing the chelation burden on EDTA or sodium phytate in the formulation.

The pH Verification Rule

Final pH must be confirmed after full cool-down addition and equilibration.

This is the single most commonly skipped pH management step in production. The reason it matters:

Glabridin and many of its standard co-actives — including niacinamide, tranexamic acid, and certain peptides — can influence the final equilibrium pH of a buffered system upon addition during the cool-down phase. A base formula buffered to pH 5.5 before active addition may change after all actives are incorporated. Always reserve a citric acid solution for final pH correction after all actives are incorporated.

Common production error: If the pH check occurs only before cool-down additions, any shift goes undetected — and the product may ship outside the intended stability range without the formulator knowing.

Practical SOP protocol

  1. Buffer aqueous phase to target pH (typically 4.5–5.2) before emulsification
  2. Complete emulsification at standard temperatures
  3. Begin cool-down; add all actives in order below 50°C
  4. Measure pH at 30–35°C under fully equilibrated conditions
  5. Adjust pH if necessary to the target specification range using appropriate acid or base solutions, based on formulation design
  6. Record final pH in batch record before release to stability

pH and Co-Active Compatibility

pH selection affects not only glabridin stability but the compatibility of the full active system. Several high-value brightening co-actives have pH requirements that must be reconciled with glabridin's window.

Co-ActiveOptimal pH RangeCompatible with Glabridin?
Niacinamide5.0–7.0✅ Yes — overlap at 5.0–6.0
Tranexamic Acid (TXA)4.5–6.5✅ Yes — full overlap
Ascorbyl glucoside (AA-2G)5.0–7.0✅ Yes — overlap at 5.0–6.0
Magnesium ascorbyl phosphate (MAP)5.5–7.0✅ Yes — overlap at 5.5–6.5 (note: MAP stability and solubility may decrease below pH 5.5)
Dipotassium glycyrrhizate (DPG)4.5–7.5✅ Yes — full overlap
Ectoin4.0–8.0✅ Yes — full overlap
Raw L-ascorbic acid2.5–3.5❌ No — pH conflict; at pH 2.5–3.5, oxidative risk for glabridin increases
Retinol esters6.5–7.5❌ No — requires pH above glabridin's stable range
AHA (glycolic, lactic at high %)3.0–4.0⚠️ Marginal — too acidic for most glabridin formats; use PHA instead

The most practical brightening co-active stack compatible with glabridin's pH window is: glabridin + niacinamide + TXA + AA-2G, all functional between pH 5.0–6.0. This combination provides upstream tyrosinase inhibition (glabridin), modulation of inflammatory and plasmin-related signaling associated with melanogenesis (tranexamic acid), melanosome transfer blockade (niacinamide), and antioxidant-mediated inhibition of melanin formation and oxidation processes (AA-2G) — four complementary intercept points in the pigmentation pathway, broadly compatible within the same mildly acidic to near-neutral pH window.

Practical Formulation Decision Tree

Is your application leave-on brightening (serum, emulsion, toner)?
Target pH typically in the mildly acidic range (approx. pH 4.5–5.5) Buffer with citric acid/sodium citrate Final pH must be confirmed after full cool-down addition and equilibration
Does your formula include niacinamide and/or TXA?
Buffer the base formulation to a slightly acidic pH (4.8–5.0) before emulsification Possible pH drift may occur following incorporation of co-actives Reserve citric acid solution for final pH correction
Is your application rinse-off or near-neutral (e.g. gentle cleanser)?
pH 6.0–6.5 may be used — reinforce antioxidant + chelation Run accelerated stability; monitor color change closely If pH must exceed 6.5, evaluate alternative brightening actives
Does your formula require pH > 7.0 (e.g. retinol, certain peptides)?
Glabridin is not suitable for this system Consider tranexamic acid or niacinamide as pH-compatible alternatives

Every batch ships with COA, TDS, and SDS/MSDS. Additional testing available upon request.

Request samples, COA, or technical consultation glabridinchina.com · [email protected] · +86 17868678161
Contact Us →

References

  1. Ao M, Shi Y, Cui Y, Guo W, Wang J, Yu L. Factors influencing glabridin stability. Natural Product Communications, Vol. 5(12), 1907–1912, 2010. DOI: 10.1177/1934578X1000501214. PMID: 21299118.
  2. Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Research, 11(6), 355–361, 1998. DOI: 10.1111/j.1600-0749.1998.tb00494.x.
  3. ICH Q1A(R2): Stability Testing of New Drug Substances and Products. International Council for Harmonisation, 2003.